Transcatheter aortic valve replacement (TAVR) has become a mainstay in treatment for
patients with severe aortic stenosis who are considered high-risk surgical candidates. The …

Introduction Transcatheter aortic valve implantation (TAVI) has been demonstrated to be an
alternative treatment for severe aortic stenosis in patients considered as high surgical risk …

Background Transcatheter aortic valve implantation (TAVI) is an option for treatment for
patients with severe aortic stenosis who are at high risk for death with surgical aortic valve …

Concerns regarding the longevity of TAVR in low-risk individuals notwithstanding, results
from PARTNER 3 indicate that TAVR is at least noninferior to SAVR out to 2 years. Longer …

Transcatheter aortic valve implantation (TAVI) is becoming a standard treatment option for
patients with severe symptomatic aortic stenosis (sSAS). As the comparative clinical …

Background Transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve
demonstrates good 30 day clinical outcomes in patients with severe aortic stenosis who are …

Objective To determine the cost-effectiveness of transcatheter aortic valve implantation
(TAVI) compared with surgical aortic valve replacement (SAVR) in a high-risk aortic stenosis …

Objectives We performed a meta‐analysis to evaluate the efficacy and safety of
transcatheter aortic valve replacement (TAVR) in comparison to surgical aortic valve …

Introduction Transcatheter aortic valve replacement (TAVR) has become the standard
treatment option for patients with symptomatic severe aortic stenosis (AS) with high surgical …

Abstract Transcatheter Aortic Valve Implantation (TAVI) has revolutionized the treatment of
elderly patients with symptomatic severe aortic stenosis (AS). Initially tested in unoperable or …